Abstract
The protection afforded by a combined enteric and cholera vaccine administered by the intradermal route, and demonstrated by active and passive mouse protection tests and agglutination titres, is excellent and equal to that given individually by the component TAB and cholera vaccines.In order to reduce the number of injections required and the unpleasant reactions provoked it is suggested that combined enteric and cholera vaccine administered by the intradermal route is of value, where appropriate, for the vaccination of travellers, and for the rapid protection of non-immune persons in the event of natural disasters or mobilization.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
